FDA releases guidance with recommendations for drug manufacturers regarding good manufacturing practices and data integrity
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice